Role of Pharmacovigilance in Precision Medicine Market
Summary
LONDON--(BUSINESS WIRE)--Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement- Pharmacovigilance: Improving Drug Development Amid The Covid-19 Crisis The case study aligns perfectly with Quantzig’s commitment to helping its clients transform business processes using data and analytical insights. According to Quantzig’s pharmacovigilance experts, “To succeed in today’s precision medicine market, one must overcome the challenges facing the sector by devising appropriate strategies to skillfully tackle unfavorable situations.” The client is a leading player in the German precision medicine market, offering a diverse portfolio of products for both treatment and prevention of diseases, including prescription drugs, generics, and other solutions targeted at both the physician and individual consumer-level. Quantzig’s pharmacovigilance analytics solutions have helped leading pharmaceutical, biotech, and life sciences companies worldwide. Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making.